Incidence of Defibrillator Shocks After Elective Generator Exchange Following Uneventful First Battery Life

نویسندگان

  • Faisal M. Merchant
  • Paul Jones
  • Scott Wehrenberg
  • Michael S. Lloyd
  • Leslie A. Saxon
چکیده

BACKGROUND A significant number of implantable cardioverter-defibrillator (ICD) patients do not experience shocks after ICD implant. Elective generator exchange (GE) has been associated with increased risk of infection and ICD lead failure. There is a paucity of contemporary data reporting on shock incidence with replacement devices. METHODS AND RESULTS Patients undergoing elective GE (n=24 203) who transmit data remotely via a remote monitoring system were analyzed to determine the incidence of ICD shocks after GE. A total of 16 230 patients (67%) did not experience a shock with the first ICD (group A), and 7973 (33%) received at least 1 shock (group B). Patients in group A were older (71.3 versus 68.8 years, P<0.001) and more often female (71% versus 77% male, P<0.001). Over an average follow-up of 1.9±1.2 years after GE, the proportion of patients with shocks and risk of ICD shocks was lower for those who did not receive a shock during the first battery life (group A: 9.9% versus 27.7%, hazard ratio 0.36, 95% CI 0.34 to 0.38, P<0.001). The cumulative rate of ICD shocks at 5 years after GE was 25.7% in group A and 51.1% in group B. CONCLUSIONS In this large cohort of ICD patients implanted across the United States, two thirds did not receive ICD shock therapy prior to GE. The occurrence of ICD shocks prior to GE is an important predictor of shocks after GE; however, even among those without shocks during first battery life, the incidence of shocks at 5 years following GE is >25%. These data should support informed decision making for patients and physicians at the time of ICD generator end of service.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Clinical profile and incidence of ventricular arrhythmia in patients undergoing defibrillator generator replacement in Spain.

INTRODUCTION AND OBJECTIVES Implantable cardioverter-defibrillators reduce mortality in some patients with heart disease. Battery replacement is a frequent occurrence in clinical practice and is required in up to 30% of implants. The benefit/risk ratio of defibrillators varies over time and should be reevaluated at the time of replacement. The aim of this study was to determine the clinical cha...

متن کامل

Restratification at Time of Implantable Cardioverter Defibrillator Replacement Reestratificación en el momento del recambio del desfibrilador automático implantable

Based on the results of several large, randomized, clinical trials, implantable cardioverter defibrillators (ICDs) have become a ‘‘gold standard’’ therapy in prevention of sudden cardiac death. Under current guidelines, ICDs are implanted in patients who survived cardiac arrest or hemodynamically unstable ventricular tachycardia, as well as in primary prevention, mainly for those with ischemic ...

متن کامل

Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement.

AIMS The number of implantable cardioverter defibrillator (ICD) implantations, as well as follow-up procedures such as generator exchanges, lead revisions and lead system upgrades, is ever-increasing. Lead revisions and implantation of additional leads require venous access at the site of the previous ICD implantation. The aim of our study was therefore to evaluate the incidence of venous obstr...

متن کامل

In sickness and in health, till death do us part: Is the ICD a lifelong commitment?

The decision-making process around initial implantation of an Implantable Cardioverter Defibrillator (ICD) is well studied, guided by randomized clinical trials which have translated into widely accepted clinical guidelines. For patients who out-live their first device and are eligible for a generator exchange (GE) the indications to replace the battery is much less well-defined. In this latter...

متن کامل

Restratification at time of implantable cardioverter defibrillator replacement.

Based on the results of several large, randomized, clinical trials, implantable cardioverter defibrillators (ICDs) have become a ‘‘gold standard’’ therapy in prevention of sudden cardiac death. Under current guidelines, ICDs are implanted in patients who survived cardiac arrest or hemodynamically unstable ventricular tachycardia, as well as in primary prevention, mainly for those with ischemic ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 3  شماره 

صفحات  -

تاریخ انتشار 2014